Clearstead Trust’s Dorman Products DORM Stock Holding History

Clearstead Trust’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12	Closed	-$1.87K	–	1151
2025 Q3	$1.87K	Hold	12	–	–	﹤0.01%	1017
2025 Q2	$1.47K	Buy	+12	New	+$1.46K	﹤0.01%	1037

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Clearstead Trust's DORM Position: Q4 2025 in Review

Clearstead Trust sold out of Dorman Products (DORM) in Q4 2025, closing a stake of 12 shares — an estimated $1.87K sold.

Clearstead Trust first reported a position in DORM in Q2 2025 and held it in 2 quarters. The position peaked at $1.87K in Q3 2025. 348 funds tracked by Wall St. Rank hold DORM as of Q4 2025.

Clearstead Trust reported no remaining Dorman Products position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 12 Dorman Products shares in Q4 2025, an estimated $1.87K.
Clearstead Trust first reported a position in Dorman Products in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Dorman Products position peaked at $1.87K in Q3 2025.
348 funds tracked by Wall St. Rank held Dorman Products as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.